March 21, 2025

Maternal overweight as risk factor for childhood leukemia in daughters

Maternal overweight as risk factor for childhood leukemia in daughters

The weight of expectant mothers could play a role in the development of acute lymphoblastic leukemia (ALL) in daughters – but not in sons. This has been shown by researchers at the German Cancer Research Center (DKFZ).

Bone marrow smear (large magnification) from a patient with acute lymphoblastic leukemia. (C) wikimedia/Furfur

Acute lymphoblastic leukemia is rare overall, but accounts for about a quarter of childhood cancers. To identify possible risk factors, a team led by Mahdi Fallah, DKFZ, together with colleagues from Lund University, analyzed data from almost 3 million births in Sweden over a period of 35 years. The data was taken from the Swedish nationwide family cancer registry.

During the study period, a total of 1,388 children in Sweden developed ALL. The results show that girls whose mothers were overweight or obese (BMI 25 and above) at the beginning of pregnancy had a 40 percent increased risk of developing ALL.

“Our results were also surprising to us,” says Mahdi Fallah, lead scientist of the study. ”They suggest that maternal obesity could be an overlooked risk factor for childhood leukemia – and that it is gender-specific.”

The researchers suspect that hormonal influences, particularly elevated estrogen levels during pregnancy, could play a role. Estrogens have been shown to affect gene expression and could increase the risk of leukemia in female offspring.

Encouragingly, the study showed no association between weight gain during pregnancy and ALL risk, which is a relief for expectant mothers concerned about their pregnancy weight gain.

The scientists are now planning further investigations to better understand the biological mechanisms behind this surprising sex-specific phenomenon. In the long term, the findings may lead to new prevention strategies. “Pregnancy is a crucial phase for a child’s health,” emphasizes Fallah. “Our results underscore the importance of educating expectant mothers about healthy lifestyle habits early on – not only for their own well-being, but also for that of their children.”

Jiaye Liu, Elham Kharazmi, Qunfeng Liang, Yafei Chen, Jan Sundquist, Kristina Sundquist and Mahdi Fallah: Maternal weight during pregnancy and risk of childhood acute lymphoblastic leukemia in offspring

Leukemia 2025, DOI: https://doi.org/10.1038/s41375-025-02517-6

Our latest News

discover more
China’s NMPA approves Promega’s MSI detection kit as a companion diagnostic for KEYTRUDA®

China’s NMPA approves Promega’s MSI detection kit as a companion diagnostic for KEYTRUDA®

The National Medical Products Administration (NMPA) in China has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic device in China. It is intended as a companion diagnostic to identify patients with MSI-high (MSI-H) solid tumors for treatment with KEYTRUDA® (pembrolizumab), the anti-PD-1 therapy from Merck & Co., Inc., […]

aimed analytics GmbH highlighted in deutsche-startups.de

aimed analytics GmbH highlighted in deutsche-startups.de

5 neue Startups: ONOX, aimed analytics, Recarbox, FORMIC, showroom.fm Es ist wieder soweit – neue Startups stehen in den Startlöchern! Hier sind einige spannende junge Unternehmen, die man kennen sollte. Heute werfen wir einen Blick auf diese Neugründungen: ONOX, aimed analytics, Recarbox, FORMIC und showroom.fm. deutsche-startups.de stellt heute erneut eine Auswahl junger Startups vor, die […]

BioMed X Launches First Research Project in Partnership with the Government of Barbados to Advance Therapy of Early Diabetic Kidney Disease

BioMed X Launches First Research Project in Partnership with the Government of Barbados to Advance Therapy of Early Diabetic Kidney Disease

Bridgetown, Barbados, January 27, 2026 – BioMed X, a leading innovation hub for pharma, today announced the launch of its first research project in partnership with the Government of Barbados and with support from the European Union’s PharmaNext Programme. The new global call for research proposals, entitled “AI-Enabled Therapy of Early Diabetic Kidney Disease in Barbados,” addresses one of the most pressing and underexplored […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp